发明授权
- 专利标题: Mikanolide derivatives, their preparation and therapeutic uses
- 专利标题(中): 米考洛德衍生物,其制备和治疗用途
-
申请号: US10250383申请日: 2002-01-11
-
公开(公告)号: US06887869B2公开(公告)日: 2005-05-03
- 发明人: Olivier Lavergne , Christophe Lanco , Grégoire Prevost , Beng Poon Teng
- 申请人: Olivier Lavergne , Christophe Lanco , Grégoire Prevost , Beng Poon Teng
- 申请人地址: FR
- 专利权人: Societe de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.)
- 当前专利权人: Societe de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.)
- 当前专利权人地址: FR
- 代理机构: Muserlian, Lucas and Mercanti
- 优先权: FR0100397 20010112; FR0114688 20011114
- 国际申请: PCTFR02/00092 WO 20020111
- 国际公布: WO0205552 WO 20020718
- 主分类号: A61K31/34
- IPC分类号: A61K31/34 ; A61K31/343 ; A61P9/10 ; A61P13/08 ; A61P31/04 ; A61P31/12 ; A61P33/00 ; A61P35/00 ; A61P43/00 ; C07D493/18 ; C07D493/08 ; C07D493/22
摘要:
The invention concerns novel mikanolide derivatives, their preparation method and their therapeutic uses, in particular as anti-cancer and anti-viral agents. The compounds correspond to general formula (1) corresponding to general sub-formulae (I)1 and (I)2, wherein: R1 represents H, SR4 or NR4R5; R2 represents SR6 or NR6R7; R3 represents OH, O(CO)R14, OSiR15R16R17, O(CO)OR18 or O(CO)NHR18, each of the radicals R4, R6, R15, R16 and R17 representing independently (in particular) an alkyl radical, the radicals R5 and R7 representing (in particular) radicals selected independently among a hydrogen atom and an alkyl radical, and each of the radicals R14 and R18 representing independently (in particular) an alkyl or cycloalkyl radical, or one among aryl, heteroaryl, aralkyl or heteroalkyl radicals optionally substituted; provided that when the compounds correspond to the general sub-formula (I)2, then R1 does not represent a hydrogen atom
公开/授权文献
信息查询